COVID-19 mortality risk factors in older people in a long-term care center
Heras et al.,
COVID-19 mortality risk factors in older people in a long-term care center,
European Geriatric Medicine, doi:10.1007/s41999-020-00432-w (date from earlier preprint)
Retrospective 100 COVID+ elderly nursing home patients, HCQ+AZ mortality 11.4% vs. control 61.9%, RR 0.18, p<0.001. Median age 85.
risk of death, 95.6% lower, RR 0.04, p = 0.004, treatment 8 of 70 (11.4%), control 16 of 30 (53.3%), NNT 2.4, adjusted per study.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Heras et al., 2 Sep 2020, retrospective, Andorra, peer-reviewed, median age 85.0, 13 authors, dosage not specified, this trial uses multiple treatments in the treatment arm (combined with AZ) - results of individual treatments may vary.
Abstract: European Geriatric Medicine (2021) 12:601–607
https://doi.org/10.1007/s41999-020-00432-w
RESEARCH PAPER
COVID‑19 mortality risk factors in older people in a long‑term care
center
Eva Heras1 · Pablo Garibaldi1 · Maite Boix1 · Oliver Valero2 · Jorge Castillo1 · Yurisan Curbelo1 · Elso Gonzalez1 ·
Obilagilio Mendoza1 · Maria Anglada1 · Joan Carles Miralles1 · Petra Llull1 · Ricard Llovera1 · Josep M. Piqué1
Received: 18 August 2020 / Accepted: 11 November 2020 / Published online: 27 November 2020
© European Geriatric Medicine Society 2020
Key summary points
Aim COVID-19 mortality risk factors in older people from a long term care center.
Findings Male gender, low Barthel index, no pharmacological treatment and lymphocytopenia are independent mortality
risk factors.
Message The independent prognostic factors identified in the present study can help to adjust the healthcare resources in
this population in case of new outbreaks of the COVID-19 pandemic.
Abstract
Purpose Despite high rates of COVID-19 infection and increased related mortality have been reported among older adults
admitted in long-term care facilities, a limited amount of information is available about the natural course of this pandemic
and prognostic factors in such population. In the current study, we aimed to investigate the epidemiologic, demographics,
clinical, or therapeutic factors that may predict the prognosis in a cohort of COVID-19 infected institutionalized older in a
nursing home.
Methods We conducted a retrospective analysis of all COVID-19 confirmed institutionalized older in a nursing home from
March 15 to June 5, 2020. Epidemiological, demographic, and frailty status before infection, and clinical, laboratory, treatment, and outcome data during infection were collected. We used bivariate analysis and multivariate logistic regression to
identify risk factors for mortality.
Results The analysis comprised all 100 COVID-19 confirmed cases during the study period. The median age was 85 years;
62% were female. The case fatality rate was 20%. In the bivariate analysis, male gender, fever, respiratory symptoms, severe
cognitive decline, a low Barthel index, and lymphocytopenia were significantly associated with mortality. Patients treated
with hydroxychloroquine plus azithromycin were related to a higher chance of survival than those without pharmacological
treatment. Multivariate logistic regression analysis identified male gender, low Barthel index, no pharmacological treatment,
and lymphocytopenia as independent risk factors associated with mortality.
Conclusions Male gender, low Barthel index, and lymphocytopenia are independent risk factors for COVID-19 mortality in
institutionalized older patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was
associated with lower mortality in these patients.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit